HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful autologous simple limbal epithelial transplantation (SLET) in previously failed paediatric limbal transplantation for ocular surface burns.

Abstract
A 3-year-old child sustained severe ocular surface burns in her left eye after accidental lime injury. Despite appropriate management in the acute stage, she developed limbal stem cell deficiency (LSCD) in that eye. This was initially treated with autologous ex vivo cultivated limbal epithelial transplantation (CLET), which unfortunately failed after 6 months resulting in recurrence of LSCD. One year following CLET, she underwent simple limbal epithelial transplantation (SLET) using autologous donor tissue from the healthy fellow eye. Successful restoration of the ocular surface following SLET combined with amblyopia therapy led to significant cosmetic and functional improvement. One year following SLET her vision in the left eye was 20/80 and she continues to maintain a stable, avascular and completely epithelised corneal surface. This case illustrates that SLET is effective in treating LSCD even in cases that are conventionally considered to be at high risk for failure of limbal stem cell transplantation.
AuthorsSwapnil Bhalekar, Sayan Basu, Ikeda Lal, Virender S Sangwan
JournalBMJ case reports (BMJ Case Rep) Vol. 2013 (May 10 2013) ISSN: 1757-790X [Electronic] England
PMID23667247 (Publication Type: Case Reports, Journal Article)
Topics
  • Amblyopia (etiology, therapy)
  • Burns, Chemical (surgery)
  • Child, Preschool
  • Corneal Diseases (surgery)
  • Corneal Transplantation
  • Epithelium, Corneal (cytology, injuries, surgery)
  • Eye Burns (surgery)
  • Female
  • Humans
  • Limbus Corneae (cytology, injuries, surgery)
  • Stem Cell Transplantation
  • Stem Cells
  • Transplantation, Autologous
  • Vision, Ocular

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: